Graham Pechenik
@calyx.law
IP law & strategy for psychedelics ventures & emerging tech ❀ DeSci ❀ Registered patent attorney ❀ UCSD biochem + cognitive neuroscience ❀ NYU Law ❀ SF/Oakland native ❀ www.calyx.law
Pinned
Graham Pechenik
@calyx.law
· Dec 9
Updated: The Psychedelic Legalization & Decriminalization Tracker, Now In Partnership with BCSP
UC Berkeley’s Center for the Science of Psychedelics joins @calyx.law as a partner on our U.S. psychedelic policy reform tracker.
Together, we will maintain this tool, which we first published in 2021.
UC Berkeley’s Center for the Science of Psychedelics joins @calyx.law as a partner on our U.S. psychedelic policy reform tracker.
Together, we will maintain this tool, which we first published in 2021.
Psychedelic reform in the US?
Delighted to collaborate with the UC Berkeley Center for the Science of Psychedelics #BCSP and @psychedelicalpha.bsky.social to launch a new interactive map to track the rapidly evolving landscape of psychedelic law and policy reform across the US
Our aim is to…
1/2
Delighted to collaborate with the UC Berkeley Center for the Science of Psychedelics #BCSP and @psychedelicalpha.bsky.social to launch a new interactive map to track the rapidly evolving landscape of psychedelic law and policy reform across the US
Our aim is to…
1/2
Reposted by Graham Pechenik
Great article, interesting points about the impact of claim scope on generic/bioequivalence considerations, and risks associated with creating a patent prosecution record that doesn't match information provided to the FDA.
Patent Analysis: Lykos Suffers Blow from USPTO As All Patent Claims Stand Finally Rejected
The ailing MDMA drug developer faces another rejection, this time from the U.S. patent office.
Read more in this free issue of our Patent Analysis:
psychedelicalpha.com/news/patent-...
The ailing MDMA drug developer faces another rejection, this time from the U.S. patent office.
Read more in this free issue of our Patent Analysis:
psychedelicalpha.com/news/patent-...
Patent Analysis: Lykos Suffers Blow from USPTO As All Patent Claims Stand Finally Rejected - Psychedelic Alpha
The US Patent and Trademark Office has dealt a substantial blow to Lykos Therapeutics’ hopes of realising meaningful patent protection for its MDMA candidate, rejecting all of its claims as obvious.
psychedelicalpha.com
January 17, 2025 at 6:20 AM
Great article, interesting points about the impact of claim scope on generic/bioequivalence considerations, and risks associated with creating a patent prosecution record that doesn't match information provided to the FDA.
Reposted by Graham Pechenik
It's a tricky time for Lykos to raise money from more conventional biotech investors.
Not only did it receive a rejection from the FDA last summer, but it also received two major rejections from the US Patent and Trademark Office, which have gone largely unreported.
Not only did it receive a rejection from the FDA last summer, but it also received two major rejections from the US Patent and Trademark Office, which have gone largely unreported.
Latest twist in Lykos saga has it all:
✅ Takeover bid led by billionaire who took drugs with Elon + helped him buy X
✅ Potential involvement of biotech exec widely accused of price gouging
✅ But also the potential to return Lykos to its public benefit mission
psychedelicalpha.com/news/billion...
✅ Takeover bid led by billionaire who took drugs with Elon + helped him buy X
✅ Potential involvement of biotech exec widely accused of price gouging
✅ But also the potential to return Lykos to its public benefit mission
psychedelicalpha.com/news/billion...
Billionaire Investor Antonio Gracias Plots $100M Lykos Takeover with Doblin’s Backing - Psychedelic Alpha
This latest twist in the Lykos Therapeutics saga threatens a major overhaul of the company’s strategy and direction, with Musk ally and billionaire investor Antonio Gracias appearing to want to take…
psychedelicalpha.com
January 11, 2025 at 1:32 AM
It's a tricky time for Lykos to raise money from more conventional biotech investors.
Not only did it receive a rejection from the FDA last summer, but it also received two major rejections from the US Patent and Trademark Office, which have gone largely unreported.
Not only did it receive a rejection from the FDA last summer, but it also received two major rejections from the US Patent and Trademark Office, which have gone largely unreported.
Psychedelic reform in the US?
Delighted to collaborate with the UC Berkeley Center for the Science of Psychedelics #BCSP and @psychedelicalpha.bsky.social to launch a new interactive map to track the rapidly evolving landscape of psychedelic law and policy reform across the US
Our aim is to…
1/2
Delighted to collaborate with the UC Berkeley Center for the Science of Psychedelics #BCSP and @psychedelicalpha.bsky.social to launch a new interactive map to track the rapidly evolving landscape of psychedelic law and policy reform across the US
Our aim is to…
1/2
Updated: The Psychedelic Legalization & Decriminalization Tracker, Now In Partnership with BCSP
UC Berkeley’s Center for the Science of Psychedelics joins @calyx.law as a partner on our U.S. psychedelic policy reform tracker.
Together, we will maintain this tool, which we first published in 2021.
UC Berkeley’s Center for the Science of Psychedelics joins @calyx.law as a partner on our U.S. psychedelic policy reform tracker.
Together, we will maintain this tool, which we first published in 2021.
December 9, 2024 at 8:54 PM
Psychedelic reform in the US?
Delighted to collaborate with the UC Berkeley Center for the Science of Psychedelics #BCSP and @psychedelicalpha.bsky.social to launch a new interactive map to track the rapidly evolving landscape of psychedelic law and policy reform across the US
Our aim is to…
1/2
Delighted to collaborate with the UC Berkeley Center for the Science of Psychedelics #BCSP and @psychedelicalpha.bsky.social to launch a new interactive map to track the rapidly evolving landscape of psychedelic law and policy reform across the US
Our aim is to…
1/2
SF frens—I hope you brave the pouring rain and join us, we’ll have hot drinks and the fire going:
Psychedelics and DeSci?
If you're in SF and interested in either, please join us Friday night for a PsyDAO meet up: lu.ma/9nxavwlp
If you're in SF and interested in either, please join us Friday night for a PsyDAO meet up: lu.ma/9nxavwlp
PsyDAO Meet Up San Francisco · Luma
Catch us in San Francisco for a meetup where the psychedelic scene meets web3. We're celebrating the wild success of the $PSY token and diving into some…
lu.ma
November 22, 2024 at 11:07 PM
SF frens—I hope you brave the pouring rain and join us, we’ll have hot drinks and the fire going:
Psychedelics and DeSci?
If you're in SF and interested in either, please join us Friday night for a PsyDAO meet up: lu.ma/9nxavwlp
If you're in SF and interested in either, please join us Friday night for a PsyDAO meet up: lu.ma/9nxavwlp
PsyDAO Meet Up San Francisco · Luma
Catch us in San Francisco for a meetup where the psychedelic scene meets web3. We're celebrating the wild success of the $PSY token and diving into some…
lu.ma
November 21, 2024 at 1:55 AM
Psychedelics and DeSci?
If you're in SF and interested in either, please join us Friday night for a PsyDAO meet up: lu.ma/9nxavwlp
If you're in SF and interested in either, please join us Friday night for a PsyDAO meet up: lu.ma/9nxavwlp